Evidence map›Paper›PMID 28547530›Full record

ArticleMolecular neurobiology2018

Reduced CaM Kinase II and CaM Kinase IV Activities Underlie Cognitive Deficits in NCKX2 Heterozygous Mice.

Shigeki Moriguchi, Satomi Kita, Yasushi Yabuki, Ryo Inagaki, Hisanao Izumi, Yuzuru Sasaki, Hideaki Tagashira, Kyoji Horie, Junji Takeda, Takahiro Iwamoto and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular neurobiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Regulation of KInternational journal of molecular sciences · 2022
    Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Shigeki MoriguchiDepartment of Pharmacology, Graduate School of Pharmaceutical Sciences, Tohoku University, 6-3 Aramaki-Aoba, Aoba-ku, Sendai, Miyagi, 980-8578, Japan.ORCID http://orcid.org/0000-0002-8147-0412
Satomi KitaDepartment of Pharmacology, Faculty of Medicine, Fukuoka University, 7-45-1, Nanakuma, Jonan-ku, Fukuoka, Fukuoka, 814-0180, Japan.
Yasushi YabukiDepartment of Pharmacology, Graduate School of Pharmaceutical Sciences, Tohoku University, 6-3 Aramaki-Aoba, Aoba-ku, Sendai, Miyagi, 980-8578, Japan.
Ryo InagakiDepartment of Pharmacology, Graduate School of Pharmaceutical Sciences, Tohoku University, 6-3 Aramaki-Aoba, Aoba-ku, Sendai, Miyagi, 980-8578, Japan.
Hisanao IzumiDepartment of Pharmacology, Graduate School of Pharmaceutical Sciences, Tohoku University, 6-3 Aramaki-Aoba, Aoba-ku, Sendai, Miyagi, 980-8578, Japan.
Yuzuru SasakiDepartment of Pharmacology, Graduate School of Pharmaceutical Sciences, Tohoku University, 6-3 Aramaki-Aoba, Aoba-ku, Sendai, Miyagi, 980-8578, Japan.
Hideaki TagashiraDepartment of Pharmacology, Faculty of Medicine, Fukuoka University, 7-45-1, Nanakuma, Jonan-ku, Fukuoka, Fukuoka, 814-0180, Japan.
Kyoji HorieDepartment of Physiology II, Nara Medical University, Nara, Japan.
Junji TakedaDepartment of Social and Environmental Medicine, Graduate School of Medicine, Osaka University, Osaka, Japan.
Takahiro IwamotoDepartment of Pharmacology, Faculty of Medicine, Fukuoka University, 7-45-1, Nanakuma, Jonan-ku, Fukuoka, Fukuoka, 814-0180, Japan. tiwamoto@fukuoka-u.ac.jp.
Kohji FukunagaDepartment of Pharmacology, Graduate School of Pharmaceutical Sciences, Tohoku University, 6-3 Aramaki-Aoba, Aoba-ku, Sendai, Miyagi, 980-8578, Japan. kfukunaga@m.tohoku.ac.jp.
Tohoku University · JPFukuoka University · JPNara Medical University · JPThe University of Osaka · JP

Funding

Ministry of Education, Culture, Sports, Science and Technology, and the Ministry of Health and Welfare of Japan 20790398Ministry of Education, Culture, Sports, Science and Technology, and the Ministry of Health and Welfare of Japan 22390109Ministry of Education, Culture, Sports, Science and Technology, and the Ministry of Health and Welfare of Japan 23590319Ministry of Education, Culture, Sports, Science and Technology, and the Ministry of Health and Welfare of Japan 25460350
6 · The paper itself

Abstract

Among five members of the K

Indexed as

AnimalsAstrocytesBehavior, AnimalBrain-Derived Neurotrophic FactorCA1 Region, HippocampalCalcineurinCalcium-Calmodulin-Dependent Protein Kinase Type 2Calcium-Calmodulin-Dependent Protein Kinase Type 4Cognition DisordersHeterozygoteHumansLong-Term PotentiationMaleMemoryMice, TransgenicModels, BiologicalBrain-Derived Neurotrophic FactorCalcineurinCalcium-Calmodulin-Dependent Protein Kinase Type 2Calcium-Calmodulin-Dependent Protein Kinase Type 4potassium-dependent sodium-calcium exchangerRNA, MessengerSodium-Calcium ExchangerCalcium/calmodulin-dependent protein kinase IICognitionHippocampusK+-dependent Na+/Ca2+ exchangersLong-term potentiation

Identifiers

PMID28547530
OpenAlexW2619328115

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.